Author name: ipessentiacom

We were recently looking at the European patent landscape of a product for Relapsing-remitting multiple sclerosis (RRMS). There are several […]

Pharma clients normally ask for product identification. Product identification is an elaborate process and one needs to go stepwise, whether

After a patent has been issued, the owner has the power to enforce the patent. However, Patents are territorial rights,

What’s your game? Most of the businesses are becoming global and technology-driven, companies everywhere are facing pressures to be on

Commercial success of pharmaceutical products is subject to several risks, like reliance on third parties, regulatory compliance, failure to gain

Dec 4th, 2020, in Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] the England and

On Nov. 30, 2020, the US District Court for the District of Delaware on remand upheld the validity of various

Nov 2020, the European Commission (EC) has fined Teva and its now subsidiary Cephalon 60.5 million euros for agreeing to

The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) established a framework for FDA approval of biosimilars. It

Most of the companies obtain an agreement from employee to assign any patents developed while working on the employer’s business